Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Global Multiple Sclerosis Drugs Market Growth 2024-2030
... market, the Multiple Sclerosis Drugs is forecast to a readjusted size of US$ 20360 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global ... Read More
-
Multiple Sclerosis Drugs Global Market Report 2024
... Inc.; Novartis International AG; F. Hoffmann-La Roche Ltd.; Bayer HealthCare LLC; Pfizer Inc. Multiple Sclerosis Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032 The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market ... Read More
-
Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and
... Africa) The global progressive multifocal leukoencephalopathy treatment market is set to experience steady growth from 2024 to 2031. Several key insights are driving this growth in the market: Factors Driving Market Growth: • Rising HIV ... Read More
-
Neurological Biomarkers Market by Type (Genomic, Imaging, Metabolomic), Application (Alzheimer’s Disease, Autism Spectrum Disorders, Multiple Sclerosis), End-user - Global Forecast 2024-2030
... expected to reach USD 10.24 billion in 2024, at a CAGR 14.05% to reach USD 22.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurological Biomarkers Market. It ... Read More
-
Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Global Forecast 2024-2030
... to reach USD 93.56 billion in 2024, at a CAGR 10.73% to reach USD 173.25 billion by 2030. Global Specialty Generics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Specialty ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Neurorehabilitation Devices Market by Products (Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators), Therapy Area (Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.42 billion in 2024, at a CAGR 7.62% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Multiple Sclerosis Market by Treatment Modality (Injectable Agents, Oral Agents), Application (Hospital, Research) - Global Forecast 2024-2030
... 18.05 billion in 2024, at a CAGR 8.25% to reach USD 29.09 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Multiple Sclerosis Market. It offers a comprehensive assessment ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
... reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive ... Read More
-
Multiple Sclerosis Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Immunosuppressants, Immunomodulators); By Route of Administration; By Region; Segment Forecast, 2024 - 2032
... USD 33.57 billion by 2032, according to a new study by Polaris Market Research. The report “Multiple Sclerosis Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Immunosuppressants, Immunomodulators); By Route of Administration; By ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... global neurological biomarkers market size is expected to reach USD 18.75 billion by 2030, expanding at a CAGR of 12.89% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increased ... Read More
-
Interferons Market Forecasts to 2030 – Global Analysis By Product (Interferon Gamma, Interferon Beta, Interferon Alpha and Other Products), Application (Multiple Sclerosis, Polycythemia Vera, Hepatitis C, Hepatitis B, Melanoma, Leukemia, AIDS, Kaposi Sarcoma, Renal Cell Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography
... Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography According to Stratistics MRC, the Global Interferons Market is ... Read More
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 33.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2022-2028. Multiple sclerosis (MS) refers to a chronic and inflammatory immune-mediated condition that can cause demyelination, axonal transection and neurodegeneration of ... Read More
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\'s Disease, Alzheimer\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030
... 11.40 billion by 2030 from USD 3.83 billion in 2022, at a CAGR of 14.60% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends ... Read More
-
United States Autoimmune Disease Diagnostics Market By Component (Instruments, Reagents, Consumables), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others), By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics) By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F
... By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, ... Read More
-
North America Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The North America medical marijuana market is expected to grow from US$ 7,170.17 million in 2022 to US$ 20,760.41 million by 2028. It is ... Read More
-
Asia Pacific Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The Asia Pacific medical marijuana market is expected to grow from US$ 2,115.23 million in 2022 to US$ 6,203.80 million by 2028. It is ... Read More
-
Europe Medical Marijuana Market Forecast to 2028 – Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The Europe medical marijuana market is expected to grow from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028. It is estimated to register a CAGR ... Read More
-
Stem Cell Therapy for Multiple Sclerosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... Sclerosis from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, ... Read More
-
Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030
... by 2030. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. Autoimmune diseases can be divided into ... Read More
Research Assistance
